MGAT5 is a peptide fragment derived from N-acetylglucosaminyltransferase V, highlighting residues essential for catalytic and structural stability. Researchers employ it to study glycosylation-site recognition and enzyme-substrate interactions. Its composition supports conformational and binding analyses in glycoprotein research.
CAT No: ta-424
MGAT5, also known as mannoside acetylglucosaminyltransferase 5, is a key glycosyltransferase enzyme involved in the biosynthesis of complex N-glycans. As a member of the glycosyltransferase family, MGAT5 catalyzes the addition of N-acetylglucosamine (GlcNAc) residues to the core mannose structures of glycoproteins, thereby regulating the branching and complexity of N-linked glycans on proteins. This enzymatic activity plays a pivotal role in modulating various cellular processes, including cell adhesion, signaling, and protein stability. MGAT5 has garnered significant attention in biochemical and cell biology research due to its critical function in glycan remodeling and its implications in cellular physiology and pathology.
Glycosylation pathway analysis: MGAT5 is widely utilized in studies aiming to elucidate the molecular mechanisms of N-glycan branching within the Golgi apparatus. By serving as a crucial enzymatic component in the late stages of N-glycan maturation, it enables researchers to dissect the sequential steps and regulatory checkpoints governing glycosylation. Investigations into MGAT5 activity and expression facilitate a deeper understanding of how glycan structures influence protein folding, trafficking, and overall cellular homeostasis. Such insights are essential for mapping the glycosylation landscape in both normal and perturbed cellular states.
Cell signaling and adhesion research: The enzyme's role in modifying the glycan structures of cell surface proteins has made it a valuable tool for exploring how glycosylation affects cell-cell and cell-matrix interactions. Alterations in MGAT5-mediated glycan branching can modulate the affinity and clustering of cell adhesion molecules, thereby impacting cellular communication, migration, and tissue organization. Experimental manipulation of MGAT5 expression or activity is frequently employed to investigate the biochemical underpinnings of cell signaling cascades, particularly those involving growth factor receptors and integrins.
Cancer biology and metastasis studies: MGAT5 is a focal point in research examining the molecular basis of tumor progression and metastasis. Enhanced N-glycan branching driven by increased enzyme activity has been correlated with changes in cellular behavior relevant to oncogenesis, such as epithelial-to-mesenchymal transition, invasiveness, and immune evasion. Utilizing MGAT5 in in vitro and in vivo models allows scientists to probe the glycomic alterations associated with malignant transformation and to identify potential biomarkers or intervention points within the glycosylation pathway.
Protein engineering and glycoprotein production: In the context of recombinant protein production, MGAT5 is applied to control and optimize glycosylation patterns of therapeutic proteins and research-grade glycoproteins. By manipulating the expression or activity of this glycosyltransferase in host cells, researchers can influence the branching and heterogeneity of N-linked glycans, thereby tailoring the physicochemical properties, stability, and biological activity of the produced proteins. This application is particularly valuable for ensuring consistency and functionality in biopharmaceutical manufacturing and for generating glycoengineered proteins with specific structural features.
Glycomic profiling and analytical method development: The enzyme is instrumental in the development and validation of analytical techniques for glycan structure elucidation. MGAT5 is used in enzymatic assays to generate defined glycan standards or to assess the branching complexity of N-glycans in biological samples. Its inclusion in glycomic workflows supports the accurate quantification and structural characterization of glycan populations, facilitating advancements in mass spectrometry, chromatography, and other high-resolution analytical platforms. These capabilities are essential for advancing the field of glycomics and for supporting research into glycan-related biological functions.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More